Wesana Health May Sell Clinics to Focus Solely on Drug Development: An Analysis
Wesana Health reaches a major strategic pivot point. Our resident Psychedelic Investor examines what this means for the company and industry at large.
Wesana Health
Elon Musk Excites Psychedelic Industry CEOs with This Tweet
This is one of the billionaire’s most explicit acknowledgments of the power of psychedelics for mental health applications.
Psychedelic Business Spotlight – February 4
Levitee Labs Announces Interim CEO and Board of Directors Shuffle…
Psychedelic Business Spotlight – December 17
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.
Psychedelic Business Spotlight – December 10
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2 companies explore a merger.
How Psychedelics Can Help End the Suicide Epidemic
There is increasing scientific evidence that a variety of psychedelics can be used to treat a number of the risk factors linked to suicide, in addition to reducing suicidality.
Psychedelic Business Spotlight: September 17, 2021
This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.
Wesana Health Launches Animal Studies for Psilocybin and TBI
According to the CDC, about 166 Americans die from TBI-related conditions each day.
How Wesana Health CEO Daniel Carcillo Plans to Protect Athletes From Traumatic Brain Injury
And why the two-time Stanley Cup champion does not imagine working with the NHL in the “near future.”
Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech
The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
End of content
End of content